Psychedelicalpha
Published October 8, 2026
Pα+ Psychedelic Bulletin #233: FDA Floats Ibogaine Trial Design; Compass Talks Pricing
Read the full story at Psychedelicalpha
FDA Floats Ibogaine Trial Design, Asks Field for Input • Compass Talks Pricing, Label and a Slow Launch • Six More Potential Psychedelic Brand.
Surfaced by 3 Google Alerts
- Psychedelics
- Ibogaine
- LSD
